Related Experiment Video
Updated: Jul 22, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Published on: December 2, 2013
p16 gene overexpression in mouse bladder carcinomas
M Asamoto1, T Hori, H Baba-Toriyama
1Chemotherapy Division, National Cancer Center Research Institute, Tokyo, Japan.
Abstract:
Deletion of 9p21 has frequently been observed in human bladder carcinomas. A candidate target suppressor gene, p16, was recently identified within this deleted region. In this study, we therefore investigated the loss of heterozygosity (LOH) of the p16 gene which is located on mouse chromosome 4, as well as its expression in mouse bladder carcinomas. We also studied the effects of normal cell contamination on LOH analysis using xenografts in CD-1(ICR) nude mice from B6C3F1 bladder carcinomas. We could not detect any LOH at the p16 locus in the mouse primary bladder carcinomas and xenografts. Surprisingly, overexpression of p16 was found in all primary mouse bladder carcinomas. Using microsatellite polymorphisms, a distinction could be made between PCR products derived from B6C3F1 and CD-1(ICR) nude mice. It was thereby confirmed that effects of normal cell contamination on LOH analysis are negligible when only tumor tissue is carefully sampled. The results suggest that abnormalities of p16 expression may be involved in mouse bladder carcinogenesis, but that gene deletion is not involved.
Insights
This study found that while gene deletion is not involved in mouse bladder cancer, abnormalities in p16 gene expression may play a role. Further research into p16 gene expression in bladder carcinomas is warranted.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Deletion at 9p21 is common in human bladder carcinomas.
- The p16 gene, a potential tumor suppressor, is located in the 9p21 region.
- Investigating p16 gene alterations in mouse bladder cancer models is crucial.
Purpose of the Study:
- To investigate loss of heterozygosity (LOH) and expression of the p16 gene in mouse bladder carcinomas.
- To assess the impact of normal cell contamination on LOH analysis using xenografts.
- To determine the role of p16 gene alterations in mouse bladder carcinogenesis.
Main Methods:
- Analysis of p16 gene LOH in primary mouse bladder carcinomas and xenografts.
- Evaluation of p16 gene expression levels in tumor samples.
- Use of microsatellite polymorphisms to differentiate between mouse strains (B6C3F1 and CD-1(ICR)) and assess contamination effects.
Main Results:
- No loss of heterozygosity (LOH) at the p16 locus was detected in mouse bladder carcinomas or xenografts.
- Surprising overexpression of the p16 gene was observed in all primary mouse bladder carcinomas.
- Careful tumor tissue sampling confirmed negligible effects of normal cell contamination on LOH analysis.
Conclusions:
- Gene deletion of p16 is not implicated in mouse bladder carcinogenesis.
- Abnormalities in p16 gene expression are suggested to be involved in mouse bladder cancer development.
- The findings highlight the importance of p16 expression rather than deletion in this cancer model.
Related Concept Videos
Abnormal Proliferation
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

